Assembly Actions -
Lowercase Senate Actions - UPPERCASE |
|
---|---|
Feb 28, 2022 |
referred to higher education delivered to assembly passed senate |
Feb 17, 2022 |
advanced to third reading |
Feb 16, 2022 |
2nd report cal. |
Feb 15, 2022 |
1st report cal.518 |
Jan 05, 2022 |
referred to health returned to senate died in assembly |
Jun 01, 2021 |
referred to higher education delivered to assembly passed senate |
May 19, 2021 |
advanced to third reading |
May 12, 2021 |
2nd report cal. |
May 11, 2021 |
1st report cal.1040 |
Apr 12, 2021 |
referred to health |
Senate Bill S6110
2021-2022 Legislative Session
Authorizes physicians and pharmacists to enter into comprehensive medication management protocols for their patients
download bill text pdfSponsored By
(D, WF) 46th Senate District
Archive: Last Bill Status - In Assembly Committee
- Introduced
-
- In Committee Assembly
- In Committee Senate
-
- On Floor Calendar Assembly
- On Floor Calendar Senate
-
- Passed Assembly
- Passed Senate
- Delivered to Governor
- Signed By Governor
Actions
Votes
-
-
-
-
Floor Vote: Feb 28, 2022
aye (63)- Addabbo Jr.
- Akshar
- Bailey
- Biaggi
- Borrello
- Boyle
- Breslin
- Brisport
- Brooks
- Brouk
- Cleare
- Comrie
- Cooney
- Felder
- Gallivan
- Gaughran
- Gianaris
- Gounardes
- Griffo
- Harckham
- Helming
- Hinchey
- Hoylman-Sigal
- Jackson
- Jordan
- Kaminsky
- Kaplan
- Kavanagh
- Kennedy
- Krueger
- Lanza
- Liu
- Mannion
- Martucci
- Mattera
- May
- Mayer
- Myrie
- O'Mara
- Oberacker
- Ortt
- Palumbo
- Parker
- Persaud
- Ramos
- Rath III
- Reichlin-Melnick
- Ritchie
- Rivera
- Ryan
- Salazar
- Sanders Jr.
- Savino
- Sepúlveda
- Serino
- Serrano
- Skoufis
- Stavisky
- Stec
- Stewart-Cousins
- Tedisco
- Thomas
- Weik
-
-
-
Floor Vote: Jun 1, 2021
aye (63)- Addabbo Jr.
- Akshar
- Bailey
- Benjamin
- Biaggi
- Borrello
- Boyle
- Breslin
- Brisport
- Brooks
- Brouk
- Comrie
- Cooney
- Felder
- Gallivan
- Gaughran
- Gianaris
- Gounardes
- Griffo
- Harckham
- Helming
- Hinchey
- Hoylman-Sigal
- Jackson
- Jordan
- Kaminsky
- Kaplan
- Kavanagh
- Kennedy
- Krueger
- Lanza
- Liu
- Mannion
- Martucci
- Mattera
- May
- Mayer
- Myrie
- O'Mara
- Oberacker
- Ortt
- Palumbo
- Parker
- Persaud
- Ramos
- Rath III
- Reichlin-Melnick
- Ritchie
- Rivera
- Ryan
- Salazar
- Sanders Jr.
- Savino
- Sepúlveda
- Serino
- Serrano
- Skoufis
- Stavisky
- Stec
- Stewart-Cousins
- Tedisco
- Thomas
- Weik
-
Feb 15, 2022 - Health Committee Vote
S611015Aye0Nay0Aye with Reservations0Absent0Excused0Abstained -
-
co-Sponsors
(D) 15th Senate District
2021-S6110 (ACTIVE) - Details
- See Assembly Version of this Bill:
- A6699
- Current Committee:
- Assembly Higher Education
- Law Section:
- Public Health Law
- Laws Affected:
- Add Art 29-H §2999-ff, Pub Health L; add §6801-c, Ed L; amd §5, Chap 21 of 2011
- Versions Introduced in Other Legislative Sessions:
-
2017-2018:
S7682, A8664
2019-2020: S5296, A3849
2023-2024: S3591
2021-S6110 (ACTIVE) - Sponsor Memo
BILL NUMBER: S6110 SPONSOR: BRESLIN TITLE OF BILL: An act to amend the public health law and the education law, in relation to comprehensive medication management; and to amend chapter 21 of the laws of 2011 amending the education law relating to authorizing pharma- cists to perform collaborative drug therapy management with physicians in certain settings, in relation to making the provisions of such chap- ter permanent PURPOSE OR GENERAL IDEA OF BILL: Authorizes physicians to refer selected patients to qualified pharma- cists for comprehensive medication management (CMM) services specified in a written protocol issued by the treating physician with consent of the patient. SUMMARY OF PROVISIONS:
Section 1 adds Article 29-H to Public Health Law entitled Comprehensive Medication Management, includes definitions and authorizes a treating physician to refer one or more patients to a qualified pharmacist for comprehensive medication management services specified in the written protocol. Section 1 defines patients eligible for referral by their treating physician as those with a chronic disease or diseases, who have not met the clinical goals of therapy, are at risk for hospitalization, or who are otherwise in need of extra medication-related services as determined by their physician. Section 1 of the bill lists medication- related services. The written protocol applies to an individual named pharmacist and a named physician and is voluntary for all parties including the patient. This section requires sharing of patient data in real-time through a bi-directional interoperable medical records system. Section 2 amends Section 6801 of the Education Law to create a new para- graph Section 6801-b. This section recognizes comprehensive medication management as a service that can be provided by a qualified pharmacist pursuant to a protocol with a licensed physician, and conforms to chang- es being made in Public Health Law. Section 3 amend s Section 5 of chapter 21 of the laws of 2011, amending the education law relating to authorizing pharmacists to perform colla- borative, drug therapy management with physicians in hospital facilities to remove the sunset and make the law permanent. Section 4 establishes the effective date. DIFFERENCE BETWEEN ORIGINAL AND AMENDED VERSION (IF APPLICABLE): Deletion of Section 1 (c) language: but not limited to electronic bidi- rectional. Insert language Section 1(c): as specified in a comprehensive medication management protocol JUSTIFICATION: Comprehensive Medication Management (CMM) has been accepted by the Health Department as a policy recommendation from a Value-Based Payment stakeholder workgroup. CMM is a professional service provided by quali- fied pharmacists to patients who are referred by their treating physi- cians for extra medication support services. The service represents a targeted strategy developed to reduce avoidable hospitalizations and healthcare costs resulting from the exacerbation of chronic diseases due to sub-optimal medication use. With expertise in pharmacotherapy and pharmacokinetics, pharmacists are uniquely positioned healthcare provid- ers to address medication-related problems. One key aspect of profes- sional practice is patient counseling which includes an assessment of a patient's understanding of how to use the medication, what side-effects to expect, how to manage them, what side-effects are dangerous and should be reported, etc. Patients are not compliant for many reasons, and pharmacists are well equipped for effective one-to-one discussions that produce positive results. Peer-reviewed studies in published liter- ature consistently document the effectiveness of increasing direct interactions between pharmacists and patients. In fact, the evidence was so compelling that the Centers for Medicaid and Medicare included Medi- cation Therapy Management as a mandatory element in Medicare Part 1-) Prescription Drug Plans. CMM represents a logical progression. Under CMM, only at-risk patients receive the additional service. Patients are identified by their treating physicians and referred to an individual pharmacist with whom the treating physician has developed a written protocol for a particular patient related to a particular disease or diseases. As Value-Based payment methodologies evolve and quality is increasingly measured by therapeutic outcomes in defined patient popu- lations, the need for CMM services by pharmacists will become more and more apparent. In fact, QARR and HEDIS measures currently include many directly concerned with medication adherence, for example: medication management for people with asthma, statin therapy for patients with diabetes, persistence of beta-blocker treatment after a heart attack, antidepressant medication management, and adherence to antipsychotic medications for people with schizophrenia. CMM as described in the bill applies to pharmacists in community settings as well as patients with chronic medical conditions and their treating physicians who have relation ships with local pharmacists. The protocols envisioned in this proposal will deal with common conditions such as asthma, diabetes, hypertension and hypercholesterolemia. This legislation represents a modest and logical extension to the services that pharmacists in commu- nity practice settings can provide if they meet the additional quali- fications included in the bill. Finally, under current Education Law pharmacists employed in hospitals who meet additional qualification requirements receive a credential from the Education Department author- izing them to enter into collaborative agreements with physicians in hospitals. This bill removes the sunset on this section of law which has been in place since 2011, making it permanent. PRIOR LEGISLATIVE HISTORY: 2017-2018 A.8664-A/S.7682 2019-2020 A.3849/S.5296 FISCAL IMPLICATIONS FOR STATE AND LOCAL GOVERNMENTS: This legislation is expected to result in a savings for the State under Medicaid and other public programs. EFFECTIVE DATE: This act shall take effect immediately, provided that sections one and two of this act shall take effect on the one hundred eightieth day after it shall have become a law provided, that, effective immediately, the addition, amendment and/or repeal of any rule or regulation necessary for the implementation of this act on its effective date is authorized and directed to be made and completed on or before such effective date.
2021-S6110 (ACTIVE) - Bill Text download pdf
S T A T E O F N E W Y O R K ________________________________________________________________________ 6110 2021-2022 Regular Sessions I N S E N A T E April 12, 2021 ___________ Introduced by Sen. BRESLIN -- read twice and ordered printed, and when printed to be committed to the Committee on Health AN ACT to amend the public health law and the education law, in relation to comprehensive medication management; and to amend chapter 21 of the laws of 2011 amending the education law relating to authorizing phar- macists to perform collaborative drug therapy management with physi- cians in certain settings, in relation to making the provisions of such chapter permanent THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM- BLY, DO ENACT AS FOLLOWS: Section 1. The public health law is amended by adding a new article 29-H to read as follows: ARTICLE 29-H COMPREHENSIVE MEDICATION MANAGEMENT SECTION 2999-FF. COMPREHENSIVE MEDICATION MANAGEMENT. § 2999-FF. COMPREHENSIVE MEDICATION MANAGEMENT. 1. DEFINITIONS. AS USED IN THIS ARTICLE, THE FOLLOWING TERMS SHALL HAVE THE FOLLOWING MEAN- INGS: (A) QUALIFIED PHARMACIST. THE TERM "QUALIFIED PHARMACIST" SHALL MEAN A PHARMACIST WHO MAINTAINS A CURRENT UNRESTRICTED LICENSE PURSUANT TO ARTICLE ONE HUNDRED THIRTY-SEVEN OF THE EDUCATION LAW, WHO HAS A MINIMUM OF TWO YEARS OF EXPERIENCE IN PATIENT CARE AS A PRACTICING PHARMACIST WITHIN THE LAST FIVE YEARS, AND WHO HAS DEMONSTRATED COMPETENCY IN THE MEDICATION MANAGEMENT OF PATIENTS WITH A CHRONIC DISEASE OR DISEASES, INCLUDING, BUT NOT LIMITED TO, THE COMPLETION OF ONE OR MORE PROGRAMS WHICH ARE ACCREDITED BY THE ACCREDITATION COUNCIL FOR PHARMACY EDUCA- TION, RECOGNIZED BY THE EDUCATION DEPARTMENT AND ACCEPTABLE TO THE PATIENT'S TREATING PHYSICIAN. (B) PATIENT CARE. THE TERM "PATIENT CARE" SHALL MEAN ASSESSING THE APPROPRIATENESS OF PRESCRIPTION AND NON-PRESCRIPTION DRUGS FOR INDIVID- UAL PATIENTS BASED ON AN ASSESSMENT OF THE PATIENT'S MEDICATION HISTORY, EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets [ ] is old law to be omitted.
LBD10613-01-1 S. 6110 2 MEDICATION EXPERIENCE INCLUDING BELIEFS, CONCERNS, UNDERSTANDING AND EXPECTATIONS, THE CLINICAL GOALS OF THERAPY, POTENTIAL DRUG-TO-DRUG INTERACTIONS OR OTHER MEDICATION SAFETY CONCERNS, RECOMMENDATIONS FOR ADHERENCE AND CONSULTING WITH A PATIENT OR CAREGIVER. (C) COMPREHENSIVE MEDICATION MANAGEMENT. THE TERM "COMPREHENSIVE MEDI- CATION MANAGEMENT" SHALL MEAN A PROGRAM CONDUCTED BY A QUALIFIED PHARMA- CIST THAT ENSURES A PATIENT'S MEDICATIONS, WHETHER PRESCRIPTION OR NONPRESCRIPTION, ARE INDIVIDUALLY ASSESSED TO DETERMINE THAT EACH MEDI- CATION IS APPROPRIATE FOR THE PATIENT, EFFECTIVE FOR THE MEDICAL CONDI- TION, SAFE GIVEN THE COMORBIDITIES AND OTHER MEDICATIONS BEING TAKEN, AND ABLE TO BE TAKEN BY THE PATIENT AS INTENDED. COMPREHENSIVE MEDICA- TION MANAGEMENT CONDUCTED BY A QUALIFIED PHARMACIST SHALL INCLUDE SHAR- ING OF APPLICABLE PATIENT CLINICAL INFORMATION WITH THE TREATING PHYSI- CIAN AS SPECIFIED IN A COMPREHENSIVE MEDICATION MANAGEMENT PROTOCOL. (D) COMPREHENSIVE MEDICATION MANAGEMENT PROTOCOL. THE TERM "COMPREHEN- SIVE MEDICATION MANAGEMENT PROTOCOL" SHALL MEAN A WRITTEN DOCUMENT PURSUANT TO AND CONSISTENT WITH ANY APPLICABLE STATE AND FEDERAL REQUIREMENTS, THAT IS ENTERED INTO VOLUNTARILY BY A PHYSICIAN LICENSED PURSUANT TO ARTICLE ONE HUNDRED THIRTY-ONE OF THE EDUCATION LAW AND A QUALIFIED PHARMACIST WHICH ADDRESSES A CHRONIC DISEASE OR DISEASES AS DETERMINED BY THE TREATING PHYSICIAN AND THAT DESCRIBES THE NATURE AND SCOPE OF THE COMPREHENSIVE MEDICATION MANAGEMENT SERVICES TO BE PERFORMED BY THE QUALIFIED PHARMACIST, IN ACCORDANCE WITH THE PROVISIONS OF THIS ARTICLE. COMPREHENSIVE MEDICATION MANAGEMENT PROTOCOLS BETWEEN LICENSED PHYSICIANS AND QUALIFIED PHARMACISTS SHALL BE MADE AVAILABLE TO THE DEPARTMENT FOR REVIEW AND TO ENSURE COMPLIANCE WITH THIS ARTICLE, UPON REQUEST. 2. AUTHORIZATION TO ESTABLISH COMPREHENSIVE MEDICATION MANAGEMENT PROTOCOLS. A PHYSICIAN LICENSED PURSUANT TO ARTICLE ONE HUNDRED THIRTY- ONE OF THE EDUCATION LAW SHALL BE AUTHORIZED TO VOLUNTARILY ESTABLISH A COMPREHENSIVE MEDICATION MANAGEMENT PROTOCOL WITH A QUALIFIED PHARMACIST TO PROVIDE COMPREHENSIVE MEDICATION MANAGEMENT SERVICES FOR A PATIENT WHO HAS NOT MET CLINICAL GOALS OF THERAPY, IS AT RISK FOR HOSPITALIZA- TION OR FOR WHOM THE PHYSICIAN DEEMS IT IS NECESSARY TO RECEIVE COMPRE- HENSIVE MEDICATION MANAGEMENT SERVICES. PARTICIPATION BY THE PATIENT IN COMPREHENSIVE MEDICATION MANAGEMENT SERVICES SHALL BE VOLUNTARY. 3. SCOPE OF COMPREHENSIVE MEDICATION MANAGEMENT PROTOCOLS. UNDER A COMPREHENSIVE MEDICATION MANAGEMENT PROTOCOL, A QUALIFIED PHARMACIST SHALL BE PERMITTED TO: (A) ADJUST OR MANAGE A DRUG REGIMEN OF A PATIENT, PURSUANT TO THE PATIENT SPECIFIC ORDER OR PROTOCOL ESTABLISHED BY THE PATIENT'S TREATING PHYSICIAN, WHICH MAY INCLUDE ADJUSTING DRUG STRENGTH, FREQUENCY OF ADMINISTRATION OR ROUTE OF ADMINISTRATION. ADJUSTING THE DRUG REGIMEN SHALL NOT INCLUDE SUBSTITUTING OR SELECTING A DIFFERENT DRUG WHICH DIFFERS FROM THAT INITIALLY PRESCRIBED BY THE PATIENT'S TREATING PHYSI- CIAN UNLESS SUCH SUBSTITUTION IS EXPRESSLY AUTHORIZED IN THE WRITTEN ORDER OR PROTOCOL. THE QUALIFIED PHARMACIST SHALL BE REQUIRED TO IMME- DIATELY DOCUMENT IN THE PATIENT'S MEDICAL RECORD CHANGES MADE TO THE PATIENT'S DRUG THERAPY. THE PATIENT'S TREATING PHYSICIAN MAY PROHIBIT, BY WRITTEN INSTRUCTION, ANY ADJUSTMENT OR CHANGE IN THE PATIENT'S DRUG REGIMEN BY THE QUALIFIED PHARMACIST; (B) EVALUATE AND, ONLY IF SPECIFICALLY AUTHORIZED BY THE PROTOCOL AND ONLY TO THE EXTENT NECESSARY TO DISCHARGE THE RESPONSIBILITIES SET FORTH IN THIS ARTICLE, ORDER DISEASE STATE LABORATORY TESTS RELATED TO THE DRUG THERAPY MANAGEMENT FOR THE SPECIFIC CHRONIC DISEASE OR DISEASES SPECIFIED WITHIN THE WRITTEN AGREEMENT OR PROTOCOL; S. 6110 3 (C) ONLY IF SPECIFICALLY AUTHORIZED BY THE WRITTEN ORDER OR PROTOCOL AND ONLY TO THE EXTENT NECESSARY TO DISCHARGE THE RESPONSIBILITIES SET FORTH IN THIS ARTICLE, ORDER OR PERFORM ROUTINE PATIENT MONITORING FUNC- TIONS AS MAY BE NECESSARY IN THE DRUG THERAPY MANAGEMENT, INCLUDING THE COLLECTING AND REVIEWING OF PATIENT HISTORIES, AND ORDERING OR CHECKING PATIENT VITAL SIGNS, INCLUDING PULSE, TEMPERATURE, BLOOD PRESSURE, WEIGHT AND RESPIRATION; AND (D) ACCESS THE COMPLETE PATIENT MEDICAL RECORD MAINTAINED BY THE TREATING PHYSICIAN WITH WHOM THE QUALIFIED PHARMACIST HAS THE COMPREHEN- SIVE MEDICATION MANAGEMENT PROTOCOL AND DOCUMENT ANY ADJUSTMENTS MADE PURSUANT TO THE PROTOCOL IN THE PATIENT'S MEDICAL RECORD AND SHALL NOTI- FY THE PATIENT'S TREATING PHYSICIAN OF ANY ADJUSTMENTS IN A TIMELY MANNER ELECTRONICALLY OR BY OTHER MEANS. (E) UNDER NO CIRCUMSTANCES, SHALL THE QUALIFIED PHARMACIST BE PERMIT- TED TO DELEGATE COMPREHENSIVE MEDICATION MANAGEMENT SERVICES TO ANY OTHER LICENSED PHARMACIST OR OTHER PHARMACY PERSONNEL. 4. MEDICATION ADJUSTMENTS. ANY MEDICATION ADJUSTMENTS MADE BY THE QUALIFIED PHARMACIST PURSUANT TO THE COMPREHENSIVE MEDICATION MANAGEMENT PROTOCOL INCLUDING ADJUSTMENTS IN DRUG STRENGTH, FREQUENCY OR ROUTE OF ADMINISTRATION, OR INITIATION OF A DRUG WHICH DIFFERS FROM THAT INITIAL- LY PRESCRIBED AND AS DOCUMENTED IN THE PATIENT'S MEDICAL RECORD SHALL BE DEEMED AN ORAL PRESCRIPTION AUTHORIZED BY AN AGENT OF THE PATIENT'S TREATING PHYSICIAN AND SHALL BE DISPENSED CONSISTENT WITH SECTION SIXTY-EIGHT HUNDRED TEN OF THE EDUCATION LAW. FOR THE PURPOSES OF THIS ARTICLE, A PHARMACIST WHO IS NOT AN EMPLOYEE OF THE PHYSICIAN MAY BE AUTHORIZED TO SERVE AS AN AGENT OF THE PHYSICIAN. 5. REFERRALS. A PHYSICIAN LICENSED PURSUANT TO ARTICLE ONE HUNDRED THIRTY-ONE OF THE EDUCATION LAW WHO HAS RESPONSIBILITY FOR THE TREATMENT AND CARE OF A PATIENT FOR A CHRONIC DISEASE OR DISEASES AS DETERMINED BY THE PHYSICIAN MAY REFER THE PATIENT TO A QUALIFIED PHARMACIST FOR COMPREHENSIVE MEDICATION MANAGEMENT SERVICES, PURSUANT TO THE COMPREHEN- SIVE MEDICATION MANAGEMENT PROTOCOL THAT THE PHYSICIAN HAS ESTABLISHED WITH THE QUALIFIED PHARMACIST. THE PROTOCOL AGREEMENT SHALL AUTHORIZE THE PHARMACIST TO SERVE AS AN AGENT OF THE PHYSICIAN AS DEFINED BY THE PROTOCOL. SUCH REFERRAL SHALL BE DOCUMENTED IN THE PATIENT'S MEDICAL RECORD. 6. PATIENT PARTICIPATION. PARTICIPATION IN COMPREHENSIVE MEDICATION MANAGEMENT SERVICES SHALL BE VOLUNTARY, AND NO PATIENT, PHYSICIAN OR PHARMACIST SHALL BE REQUIRED TO PARTICIPATE. THE REFERRAL OF A PATIENT FOR COMPREHENSIVE MEDICATION MANAGEMENT SERVICES AND THE PATIENT'S RIGHT TO CHOOSE TO NOT PARTICIPATE SHALL BE DISCLOSED TO THE PATIENT. COMPRE- HENSIVE MEDICATION MANAGEMENT SERVICES SHALL NOT BE UTILIZED UNLESS THE PATIENT OR THE PATIENT'S AUTHORIZED REPRESENTATIVE CONSENTS, IN WRITING, TO SUCH SERVICES. SUCH CONSENT SHALL BE NOTED IN THE PATIENT'S MEDICAL RECORD. IF THE PATIENT OR THE PATIENT'S AUTHORIZED REPRESENTATIVE WHO CONSENTED CHOOSES TO NO LONGER PARTICIPATE IN SUCH SERVICES, AT ANY TIME, THE SERVICES SHALL BE DISCONTINUED AND IT SHALL BE NOTED IN THE PATIENT'S MEDICAL RECORD. § 2. The education law is amended by adding a new section 6801-c to read as follows: § 6801-C. COMPREHENSIVE MEDICATION MANAGEMENT. 1. AS USED IN THIS SECTION: (A) "COMPREHENSIVE MEDICATION MANAGEMENT" SHALL MEAN A PROGRAM FOR THE MANAGEMENT OF CHRONIC DISEASE OR DISEASES THAT ENSURES A PATIENT'S MEDI- CATIONS, WHETHER PRESCRIPTION OR NONPRESCRIPTION, ARE INDIVIDUALLY ASSESSED TO DETERMINE THAT EACH MEDICATION IS APPROPRIATE FOR THE S. 6110 4 PATIENT, EFFECTIVE FOR THE MEDICAL CONDITION, SAFE GIVEN THE COMORBIDI- TIES AND OTHER MEDICATIONS BEING TAKEN, AND ABLE TO BE TAKEN BY THE PATIENT AS INTENDED; AND (B) "COMPREHENSIVE MEDICATION MANAGEMENT PROTOCOL" SHALL MEAN A WRIT- TEN DOCUMENT, PURSUANT TO AND CONSISTENT WITH ANY APPLICABLE STATE OR FEDERAL REQUIREMENTS, THAT IS ENTERED INTO VOLUNTARILY BY A PHYSICIAN LICENSED PURSUANT TO ARTICLE ONE HUNDRED THIRTY-ONE OF THIS TITLE AND A LICENSED PHARMACIST WHO MEETS THE QUALIFICATION REQUIREMENTS SPECIFIED IN ARTICLE TWENTY-NINE-H OF THE PUBLIC HEALTH LAW WHICH ADDRESSES A CHRONIC DISEASE OR DISEASES AS DETERMINED BY THE PHYSICIAN AND THAT DESCRIBES THE NATURE AND SCOPE OF THE COMPREHENSIVE MEDICATION MANAGE- MENT SERVICE TO BE PERFORMED BY THE QUALIFIED PHARMACIST. COMPREHENSIVE MEDICATION MANAGEMENT PROTOCOLS BETWEEN LICENSED PHYSICIANS AND QUALI- FIED PHARMACISTS SHALL BE MADE AVAILABLE TO THE DEPARTMENT FOR REVIEW AND TO ENSURE COMPLIANCE WITH THIS ARTICLE, UPON REQUEST. 2. A LICENSED PHARMACIST QUALIFIED PURSUANT TO ARTICLE TWENTY-NINE-H OF THE PUBLIC HEALTH LAW IS AUTHORIZED TO SERVE AS AN AGENT OF THE PHYSICIAN WHEN EXECUTING THE TERMS OF THE WRITTEN COMPREHENSIVE MEDICA- TION MANAGEMENT PROTOCOL AS ESTABLISHED BY THE LICENSED PHYSICIAN FOR THE MANAGEMENT OF PATIENTS WITH A CHRONIC DISEASE OR DISEASES. § 3. Section 5 of chapter 21 of the laws of 2011, amending the educa- tion law relating to authorizing pharmacists to perform collaborative drug therapy management with physicians in certain settings, as amended by section 20 of part BB of chapter 56 of the laws of 2020, is amended to read as follows: § 5. This act shall take effect on the one hundred twentieth day after it shall have become a law[, provided, however, that the provisions of sections two, three, and four of this act shall expire and be deemed repealed July 1, 2022]; provided, however, that the amendments to subdi- vision 1 of section 6801 of the education law made by section one of this act shall be subject to the expiration and reversion of such subdi- vision pursuant to section 8 of chapter 563 of the laws of 2008, when upon such date the provisions of section one-a of this act shall take effect; provided, further, that effective immediately, the addition, amendment and/or repeal of any rule or regulation necessary for the implementation of this act on its effective date are authorized and directed to be made and completed on or before such effective date. § 4. This act shall take effect immediately, provided that sections one and two of this act shall take effect on the one hundred eightieth day after it shall have become a law. Effective immediately, the addi- tion, amendment and/or repeal of any rule or regulation necessary for the implementation of this act on its effective date are authorized to be made and completed on or before such effective date.
Comments
Open Legislation is a forum for New York State legislation. All comments are subject to review and community moderation is encouraged.
Comments deemed off-topic, commercial, campaign-related, self-promotional; or that contain profanity, hate or toxic speech; or that link to sites outside of the nysenate.gov domain are not permitted, and will not be published. Attempts to intimidate and silence contributors or deliberately deceive the public, including excessive or extraneous posting/posts, or coordinated activity, are prohibited and may result in the temporary or permanent banning of the user. Comment moderation is generally performed Monday through Friday. By contributing or voting you agree to the Terms of Participation and verify you are over 13.
Create an account. An account allows you to sign petitions with a single click, officially support or oppose key legislation, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.